| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 1445993-26-9 | Mivebresib | C22H19F2N3O4S |
| 1445993-85-0 | 4-bromo-7-methoxy-1-tosyl-1H-pyrrolo[2,3-c]pyridine | C15H13BrN2O3S |
| 1446013-07-5 | Fmoc-His-Aib-OH | C25H26N4O5 |
| 1446013-08-6 | Fmoc-His-Aib-OH TFA | C25H26N4O5.C2HF3O2 |
| 1446090-77-2 | rel-5-[[(1R,1aS,6bR)-1a,6b-Dihydro-1-[6-(trifluoromethyl)-1H-benzimidazol-2-yl]-1H-cyclopropa[b]benzofuran-5-yl]oxy]-3,4-dihydro-1,8-naphthyridin-2(1H)-one | C25H17F3N4O3 |
| 1446140-91-5 | alpha-[1-(4-Chlorophenyl)cyclobutyl]-N,N-dimethylbenzeneethanamine | C20H24ClN |
| 1446144-04-2 | CPI 203 | C19H18ClN5OS |
| 1446194-56-4 | Bortezomib Impurity H | C19H24N4O2 |
| 1446261-44-4 | (10aR)-2-Fluoro-5,8,9,10,10a,11-hexahydro-10a-methyl-5,6,7a,11-tetraazacyclohepta[def]cyclopenta[a]fluoren-4(7H)-one | C16H15FN4O |
| 1446263-38-2 | 7-(2-Butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-8-[(3R)-3-piperidinylamino]-1H-purine-2,6-dione | C25H28N8O2 |
| 1446282-18-3 | 18-Amino-4,7,10,13,16-pentaoxaoctadecanoic acid 1,1-dimethylethyl ester | C17H35NO7 |
| 1446321-46-5 | 2-Hydroxy-6-[[2-[1-(1-methylethyl)-1H-pyrazol-5-yl]-3-pyridinyl]methoxy]benzaldehyde | C19H19N3O3 |
| 1446352-68-6 | 4-(4-Fluorophenyl)-N,N-dimethyl-3-(1H-pyrrol-1-yl)-1H-pyrazole-1-ethanamine | C17H19FN4 |
| 1446448-94-7 | 4-(2-Naphthalenyl)-N-[4-(2-naphthalenyl)phenyl]benzenamine | C32H23N |
| 1446448-95-8 | 4-(1-Naphthalenyl)-N-[4-(2-naphthalenyl)phenyl]benzenamine | C32H23N |
| 1446486-33-4 | 9-(1E)-1-Propen-1-yl-9H-purin-6-amine | C8H9N5 |
| 1446502-11-9 | Enasidenib | C19H17F6N7O |
| 1446507-38-5 | 6-[6-(Trifluoromethyl)-2-pyridinyl]-1,3,5-triazine-2,4(1H,3H)-dione | C9H5F3N4O2 |
| 1446507-40-9 | 2,4-Dichloro-6-[6-(trifluoromethyl)-2-pyridinyl]-1,3,5-triazine | C9H3Cl2F3N4 |
| 1446507-68-1 | 4-Chloro-6-[6-(trifluoromethyl)pyridin-2-yl]-N-[2-(trifluoromethyl)pyridin-4-yl]-1,3,5-triazin-2-amine | C15H7ClF6N6 |
| 1446509-52-9 | 3-Fluoro-6-trifluoromethylpyridine-2-carboxylic acid methyl ester | C8H5F4NO2 |
| 1446711-81-4 | 3-[3-(3,5-Dimethyl-1H-pyrazol-4-yl)propoxy]-4-fluorobenzoic acid | C15H17FN2O3 |
| 1446741-25-8 | 9-(3-Fluorophenyl)-2,3,4,4a,9,9a-hexahydro-4a,9a-dimethyl-6-(3,6,8-triphenyl-1-pyrenyl)-1H-carbazole | C54H42FN |
| 1446750-99-7 | 1,2-Bis(piperazin-1-yl)benzene | C14H22N4 |
| 1446790-62-0 | 6-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[(5,6-dimethyl-2-pyridinyl)amino]-3-pyridazinecarboxamide | C18H25N7O |
| 1447607-90-0 | 6,7-Dichloro-2-methyl-1,2,3,4-tetrahydroquinoline | C10H11Cl2N |
| 1447671-73-9 | 3-Bromo-1,1,1-trifluoro-2,2-dimethylpropane | C5H8BrF3 |
| 1447693-83-5 | Aprepitant Impurity 10 HCl | C20H19ClF7NO2 |
| 1447709-01-4 | Benzo[b]naphtho[1,2-d]thien-5-ylboronic acid | C16H11BO2S |
| 1447715-44-7 | Bisoprolol EP Impurity B | C18H31NO4 |
| 1447715-45-8 | Bisoprolol N-Aldehyde | C19H31NO5 |
| 1447759-15-0 | 3,5-Difluoro-4-[(1,1,2,3,3-pentafluoro-2-propen-1-yl)oxy]-4'-[(trans,trans)-4'-pentyl[1,1'-bicyclohexyl]-4-yl]-1,1'-biphenyl | C32H37F7O |
| 1447801-82-2 | 2-Azido-2-deoxy-1-O-[(1,1-dimethylethyl)dimethylsilyl]-3-O-(phenylmethyl)-beta-D-glucopyranose 6-benzoate | C26H35N3O6Si |
| 1447824-16-9 | Acetyl Hexapeptide 37 | |
| 1447824-23-8 | Palmitoyl Tripeptide 38 | |
| 1447938-61-5 | Tris[4-(1,1-dimethylethyl)-2-(1H-pyrazol-1-yl)pyridine]cobalt salt with 1,1,1-trifluoro-N-[(trifluoromethyl)sulfonyl]methanesulfonamide (1:3) | C36H45CoN9.3(C2F6NO4S2) |
| 1447950-85-7 | 2,4-Bis(acetylamino)-6-azido-2,4,6-trideoxy-D-mannose | C10H17N5O5 |
| 1447963-30-5 | 1-(2-Thienyl)cyclopropanemethanol | C8H10OS |
| 1447963-71-4 | 2-Diphenylphosphino-2',6'-bis(dimethylamino)-1,1'-biphenyl | C28H29N2P |
| 1447963-73-6 | CPhos Pd G3 | C41H54N3O3PPdS |
| 1447963-75-8 | [2'-(Amino)[1,1'-biphenyl]-2-yl][bis(1,1-dimethylethyl)[2',4',6'-tris(1-methylethyl)[1,1'-biphenyl]-2-yl]phosphine](methanesulfonato)palladium | C42H58NO3PPdS |
| 1448049-50-0 | N-[[(3R)-5-Chloro-3,4-dihydro-8-hydroxy-3-(methyl-d3)-1-oxo-1H-2-benzopyran-7-yl-3-d]carbonyl]-L-phenylalanine | C20H14ClD4NO6 |
| 1448169-71-8 | 1-[(3S)-3-[4-Amino-3-[2-(3,5-dimethoxyphenyl)ethynyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-pyrrolidinyl]-2-propen-1-one | C22H22N6O3 |
| 1448185-87-2 | N-[[1,1'-Biphenyl]-4-yl]-4-dibenzothiophenamine | C24H17NS |
| 1448189-80-7 | (4R)-3-Methyl-L-valyl-4-hydroxy-N-[[4-(4-methyl-5-thiazolyl)phenyl]methyl]-L-prolinamide hydrochloride (1:1) | C22H30N4O3S.HCl |
| 1448189-90-9 | (2S,4R)-4-Hydroxy-N-(4-(4-methylthiazol-5-yl)benzyl)pyrrolidine-2-carboxamide hydrochloride | C16H20ClN3O2S |
| 1448232-80-1 | 6-Ethyl-3-[[4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[[(3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]oxy]-2-pyrazinecarboxamide | C30H42N8O3 |
| 1448296-00-1 | 5,7-Dihydro-5-phenylindolo[2,3-b]carbazole | C24H16N2 |
| 1448297-52-6 | (S,R,S)-AHPC | C22H30N4O3S |
| 1448301-07-2 | Argatroban Impurity 38 | C23H35N7O7S |